Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data

Author:

Potdar Swapnil1ORCID,Ianevski Filipp1,Ianevski Aleksandr1,Tanoli Ziaurrehman1ORCID,Wennerberg Krister2,Seashore-Ludlow Brinton34,Kallioniemi Olli4,Östling Päivi4,Aittokallio Tero156ORCID,Saarela Jani1ORCID

Affiliation:

1. Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki , Finland

2. Biotech Research & Innovation Centre (BRIC), University of Copenhagen , Copenhagen, Denmark

3. Department of Medical Biochemistry and Biophysics, Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Karolinska Institutet , Stockholm , Sweden

4. Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet , Stockholm , Sweden

5. Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital , Norway

6. Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo , Norway

Abstract

Abstract Functional precision medicine (fPM) offers an exciting, simplified approach to finding the right applications for existing molecules and enhancing therapeutic potential. Integrative and robust tools ensuring high accuracy and reliability of the results are critical. In response to this need, we previously developed Breeze, a drug screening data analysis pipeline, designed to facilitate quality control, dose-response curve fitting, and data visualization in a user-friendly manner. Here, we describe the latest version of Breeze (release 2.0), which implements an array of advanced data exploration capabilities, providing users with comprehensive post-analysis and interactive visualization options that are essential for minimizing false positive/negative outcomes and ensuring accurate interpretation of drug sensitivity and resistance data. The Breeze 2.0 web-tool also enables integrative analysis and cross-comparison of user-uploaded data with publicly available drug response datasets. The updated version incorporates new drug quantification metrics, supports analysis of both multi-dose and single-dose drug screening data and introduces a redesigned, intuitive user interface. With these enhancements, Breeze 2.0 is anticipated to substantially broaden its potential applications in diverse domains of fPM.

Funder

University of Helsinki and Biocenter Finland

European Union's Horizon Europe Research & Innovation Programme

European Union's Horizon 2020 Research and Innovation Programme

Academy of Finland

Knut and Alice Wallenberg Foundation

Finnish Unix User Group Foundation

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference15 articles.

1. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat. Rev. Drug Discov.,2019

2. Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing;Tanoli;Briefings Bioinf.,2020

3. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia;Pemovska;Cancer Discov.,2013

4. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation;Pemovska;Nature,2015

5. KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia;Malani;Leukemia,2020

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3